Mythri Mudireddy

15PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersMedical mycologyGene expression (incl. microarray and other genome-wide approaches)Epidemiological modellingMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 06, 2018
The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis.

Ayalew Tefferi, Terra L Lasho, Mythri Mudireddy

|Nov 23, 2017
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients.

Ayalew Tefferi, Maura Nicolosi, Mythri Mudireddy

|Sep 07, 2017
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.

Ayalew Tefferi, Terra L Lasho, Mrinal M Patnaik

|Aug 11, 2017
Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients.

Ayalew Tefferi, Silvia Betti, Daniela Barraco

|Aug 08, 2017
Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis.

Ayalew Tefferi, Mythri Mudireddy, Naseema Gangat

Pageof 3